Murine polyomavirus-like particles induce maturation of bone marrow-derived dendritic cells and proliferation of T cells
- PMID: 16917781
- DOI: 10.1007/s00430-006-0026-x
Murine polyomavirus-like particles induce maturation of bone marrow-derived dendritic cells and proliferation of T cells
Abstract
We analysed the effects of murine polyomavirus-like particles (PLPs) on bone marrow-derived dendritic cells (BMDCs) and T cells in vitro. BMDCs activated with PLPs up-regulated CD40, CD80, CD86 and major histocompatibility complex (MHC) class II surface markers and produced proinflammatory cytokines. Chimeric PLPs [expressing the ovalbumin (OVA)-peptides OVA(257-264) or OVA(323-339)], but not wildtype PLPs, activated OVA-specific CD8 T cells and OVA-specific CD4 T cells, respectively, indicating both MHC class I and II presentation of the peptides by antigen-presenting cells. Our results suggest that PLPs may be used as vaccine adjuvants priming dendritic cells to induce potent T cell responses.
Similar articles
-
Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design.Vaccine. 2002 Dec 13;21(3-4):231-42. doi: 10.1016/s0264-410x(02)00448-6. Vaccine. 2002. PMID: 12450698
-
Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.Behring Inst Mitt. 1997 Feb;(98):197-211. Behring Inst Mitt. 1997. PMID: 9382741 Review.
-
Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.J Immunol. 1999 Jan 1;162(1):144-51. J Immunol. 1999. PMID: 9886380
-
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.Mol Immunol. 2009 Dec;47(2-3):164-74. doi: 10.1016/j.molimm.2009.09.026. Epub 2009 Oct 8. Mol Immunol. 2009. PMID: 19818504
-
Dendritic cells "in vivo": their role in the initiation of intestinal immune responses.Adv Exp Med Biol. 1995;371A:271-4. doi: 10.1007/978-1-4615-1941-6_56. Adv Exp Med Biol. 1995. PMID: 8525923 Review. No abstract available.
Cited by
-
Cf-02, a novel benzamide-linked small molecule, blunts NF-κB activation and NLRP3 inflammasome assembly and improves acute onset of accelerated and severe lupus nephritis in mice.FASEB J. 2021 Aug;35(8):e21785. doi: 10.1096/fj.202100047R. FASEB J. 2021. PMID: 34314075 Free PMC article.
-
Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system.Drug Deliv Transl Res. 2014 Jun;4(3):246-55. doi: 10.1007/s13346-013-0173-8. Drug Deliv Transl Res. 2014. PMID: 25786879
-
Alginate Particles with Ovalbumin (OVA) Peptide Can Serve as a Carrier and Adjuvant for Immune Therapy in B16-OVA Cancer Model.Med Sci Monit Basic Res. 2017 Apr 28;23:166-172. doi: 10.12659/msmbr.901576. Med Sci Monit Basic Res. 2017. PMID: 28450696 Free PMC article.
-
Advanced antigen delivery of murine survivin: chimeric virus-like particles in cancer vaccine research.Int J Biomed Sci. 2007 Sep;3(3):199-205. Int J Biomed Sci. 2007. PMID: 23675044 Free PMC article.
-
Chimeric Murine Polyomavirus Virus-Like Particles Induce Plasmodium Antigen-Specific CD8+ T Cell and Antibody Responses.Front Cell Infect Microbiol. 2019 Jun 19;9:215. doi: 10.3389/fcimb.2019.00215. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31275867 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials